Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $55.9K | +433 | $129.01 | 433 | Nov 7, 2023 | Direct | ||
transaction | RGA | Common Stock | Tax liability | -$29.8K | -192 | -44.34% | $155.05 | 241 | Nov 7, 2023 | Direct | F1 |
transaction | RGA | Common Stock | Options Exercise | $51.5K | +483 | +200.41% | $106.53 | 724 | Nov 7, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$33.2K | -214 | -29.56% | $155.05 | 510 | Nov 7, 2023 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2021 | Options Exercise | $0 | -2.58K | -49.99% | $0.00 | 2.58K | Nov 7, 2023 | Common Stock | 2.58K | $129.01 | Direct | F3 |
transaction | RGA | Stock Appreciation Right (right to purchase) 2022 | Options Exercise | $0 | -1.55K | -24.99% | $0.00 | 4.64K | Nov 7, 2023 | Common Stock | 1.55K | $106.53 | Direct | F3 |
Id | Content |
---|---|
F1 | Represents (i) 2,143 shares sold to pay the exercise price the purchase of common stock, and (ii) 192 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 241 shares. |
F2 | Represents (i) 1,063 shares sold to pay the exercise price the purchase of common stock, and (ii) 214 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 269 shares. |
F3 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |